scholarly journals Combined Treatment with Erlotinib and a Transforming Growth Factor-β Type I Receptor Inhibitor Effectively Suppresses the Enhanced Motility of Erlotinib-Resistant Non–Small-Cell Lung Cancer Cells

2013 ◽  
Vol 8 (3) ◽  
pp. 259-269 ◽  
Author(s):  
Masakuni Serizawa ◽  
Toshiaki Takahashi ◽  
Nobuyuki Yamamoto ◽  
Yasuhiro Koh
Lung Cancer ◽  
2003 ◽  
Vol 40 (3) ◽  
pp. 281-287 ◽  
Author(s):  
Hong-Tao Zhang ◽  
Qing-Yan Fei ◽  
Feng Chen ◽  
Qing-Yuan Qi ◽  
Wei Zou ◽  
...  

2004 ◽  
Vol 58 (5) ◽  
pp. 1378-1387 ◽  
Author(s):  
Katrien De Jaeger ◽  
Yvette Seppenwoolde ◽  
Harm H Kampinga ◽  
Liesbeth J Boersma ◽  
José S.A Belderbos ◽  
...  

2007 ◽  
Vol 67 (13) ◽  
pp. 6253-6262 ◽  
Author(s):  
Thibault de La Motte Rouge ◽  
Lorenzo Galluzzi ◽  
Ken A. Olaussen ◽  
Yael Zermati ◽  
Ezgi Tasdemir ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document